Approach to Portal Vein Thrombosis

Diagnostic Confirmation

The American Association for the Study of Liver Diseases recommends immediate initiation of therapeutic anticoagulation with LMWH or unfractionated heparin after confirming the diagnosis and ruling out active bleeding or bowel infarction, as early anticoagulation prevents thrombus extension and achieves recanalization in 39-80% of cases 1, 2, 3
Perform Doppler ultrasound immediately as the initial screening test, looking specifically for absence of portal vein flow, hyperechoic thrombus in the portal lumen, and flow reversal within the portal system, and proceed directly to contrast-enhanced CT scan in the portal venous phase to definitively confirm diagnosis 1, 2, 4, 6

The European Association for the Study of the Liver recommends starting therapeutic anticoagulation immediately once bowel infarction is excluded, as early initiation is the strongest predictor of recanalization, and using unfractionated heparin or LMWH at therapeutic doses, with LMWH preferred due to lower risk of heparin-induced thrombocytopenia 1, 2, 3
Transition to vitamin K antagonist targeting INR 2-3 after initial heparinization, and continue anticoagulation for a minimum of 6 months, as recanalization does not occur beyond 6 months of treatment 1, 2, 3

Thrombus extension is prevented in 100% of patients with early anticoagulation, and recanalization rates are portal vein 39%, splenic vein 80%, and superior mesenteric vein 73% 1, 3
Bleeding complications occur in 9% of anticoagulated patients, with a 2% mortality rate 1, 3

Perform follow-up CT scan at 6 months to assess portal vein recanalization, and use Doppler ultrasound early after diagnosis and then every 6 months for ongoing surveillance 1, 3, 4, 5, 6
Continue anticoagulation for several additional months after recanalization to prevent rethrombosis, and consider lifelong anticoagulation if superior mesenteric vein involvement with history suggestive of intestinal ischemia 8

Implement adequate prophylaxis for gastrointestinal bleeding before initiating anticoagulation, using either non-selective beta-blockers or endoscopic band ligation for primary prophylaxis if varices are present 8

Begin screening for portal hypertension at 6 months after diagnosis using Doppler ultrasound for splenomegaly and portosystemic collaterals, and continue annual surveillance for 5 years 9, 10